◆ NeutralXLVBBHLLYJNJABBVAMGN
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?
The Motley Fool·
State Street's XLV healthcare ETF offers broader exposure with lower costs (0.08% expense ratio) and higher dividend yield (1.6%), delivering 30% more growth over five years with lower volatility. VanEck's BBH biotech ETF provides concentrated exposure to 25 biotech stocks with higher recent returns but greater risk, making XLV the better choice for long-term investors seeking defensive characteristics.
Read Full Article at The Motley Fool →